Lv1
80 积分 2023-07-04 加入
Ifebemtinib plus garsorasib as first-line treatment for KRASG12C-mutated non-small-cell lung cancer in China: a multicentre, single-arm expansion cohort from a phase 1b/2 trial
3天前
已完结
Claudin-18 isoform 2-specific CAR T-cell therapy (satri-cel) versus treatment of physician's choice for previously treated advanced gastric or gastro-oesophageal junction cancer (CT041-ST-01): a randomised, open-label, phase 2 trial
13天前
已完结
Exome sequencing reveals genetic architecture in patients with isolated or syndromic short stature
1个月前
已完结
CAR T therapy beyond cancer: the evolution of a living drug
2个月前
已完结
Antigen experience history directs distinct functional states of CD8+ CAR T cells during the antileukemia response
2个月前
已完结
Clinical application of base editing for treating β-thalassaemia
3个月前
已完结
Target-based vs phenotypic drug discovery: opportunities and challenges with evidence-based application
3个月前
已完结
Genomic analyses identify molecular subtypes of pancreatic cancer
4个月前
已完结
Virtual microdissection identifies distinct tumor- and stroma-specific subtypes of pancreatic ductal adenocarcinoma
4个月前
已完结
Subtypes of pancreatic ductal adenocarcinoma and their differing responses to therapy
4个月前
已完结
皖公网安备34019202002308
